Antimicrobial resistance in zoonotic bacteria still high in humans, animals & food
Bacteria from humans & animals continue to show resistance to antimicrobials according to a new report published by the EFSA and the ECDC. The report highlights some emerging issues & confirms antimicrobial resistance as one of the biggest threats to public health.
Vytenis Andriukaitis, European Commissioner for Health and Food Safety reaffirmed his commitment to tackle AMR: “Levels of antimicrobial resistance still differ significantly from one EU country to another. To win the fight, we need to join our efforts and implement stringent policies on the use of antibiotics across sectors. It is vital that we all renew our commitment to fight antimicrobial resistance by focusing on the key areas set out in the EU One Health Action Plan against antimicrobial resistance.”
Among the new findings, based on data from 2016, are detection of resistance to carbapenems in poultry, an antibiotic which is not authorised for use in animals, and of ESBL-producing Salmonella Kentucky with high resistance to ciprofloxacin in humans, which was reported for the first time in four countries.
Marta Hugas, EFSA’s chief scientist said: “The detection of resistance to carbapenems in poultry and to linezolid in methicillin-resistant Staphylococcus aureusin pigs is alarming because these antibiotics are used in humans to treat serious infections. It is important that risk managers follow-up on these findings.”
Mike Catchpole, ECDC’s chief scientist commented on the results: “We are concerned to see that Salmonella and Campylobacter bacteria in humans show high levels of antimicrobial resistance. The fact that we keep detecting multidrug-resistant bacteria means that the situation is not improving. We need to investigate the origins and prevent the spread of highly resistant strains, such as ESBL-producing SalmonellaKentucky”.
Animals and foods
- Resistance to carbapenem antibiotics was detected at very low level in poultry and in chicken meat in two Member States (fifteen E. coli bacteria). Carbapenems are used to treat serious infections in humans and are not authorised for use in animals.
- Two Livestock-Associated Methicillin Resistant Staphylococcus aureus bacteria found in pigs were reported to be linezolid-resistant. Linezolid is one of the last-resort antimicrobials for the treatment of infections caused by highly-resistant MRSA.
- Combined clinical resistance to critically important antimicrobials was observed at low to very low levels in Salmonella (0.2%), Campylobacter (1%) and E. coli (1%) in poultry.
- Resistance to colistin was observed at low levels (2%) in Salmonella and E. Coli in poultry.
- Prevalence of ESBL-producing E. coli in poultry varies markedly between the Member States, from low (less than 10%) to extremely high levels (more than 70%). Bacteria that produce ESBL enzymes show multi-drug resistance to β-lactam antibiotics – a class of broad spectrum antibiotics which include penicillin derivatives, cephalosporins and carbapenems. This is the first time that the presence of extended-spectrum beta-lactamase (ESBL)-producing E. coli was monitored in poultry and poultry meat.
- One out of four infections in humans are caused by Salmonella bacteria that show resistance to three or more antimicrobials commonly used in human and animal medicine. The proportion is significantly higher in S. Kentucky and S. Infantis (76.3 and 39.4% respectively).
- For the first time, ESBL-producing S. Kentucky with high resistance to ciprofloxacin was detected in four countries. These bacteria are not possible to treat with critically important antibiotics.
- Campylobacter bacteria, which cause the most common foodborne disease in the EU, show high resistance to widely used antibiotics (ciprofloxacin resistance 54.6% in C. jejuni and 63.8% in C. coli; tetracyline resistance 42.8% in C. jejuniand 64.8% in C. coli). The levels of resistance increased in two of the three analysed antibiotics (ciprofloxacin and tetracycline) but combined resistance to the critically important antimicrobials is stable and overall low (0.6% in C. jejuniand 8.0% in C. coli). In some countries, however, at least one in three C. coli infections were multidrug-resistant to important antibiotics, leaving very few treatment options for severe infections.
Notes to editors
The categorisation of antibiotics as critically/ highly important/ important used in this news story refers to World Health Organisation’s list of critically important antimicrobials, 5th update (2017).
Latest News from
A Europe that protects: good progress on tackling hybrid threats17/06/2019 16:37:00
The EU and Member States have made good progress in tackling hybrid threats through a number of concerted actions in a wide range of sectors to significantly boost capacities, shows the latest report adopted by the EC and the European External Action Service.
European Semester 2019 Spring Package and EU budget 202017/06/2019 16:07:00
The EC has presented the 2019 country-specific recommendations, giving economic policy guidance to all EU Member States for the next 12 to 18 months.
Delegated & implementing acts: EU adapts a significant number of legislative acts to the Lisbon Treaty17/06/2019 15:25:00
The Council has adopted a regulation aligning 64 legislative acts which refer to the so-called 'regulatory procedure with scrutiny' with the Lisbon Treaty.
The EU strengthens rules on home-made explosives and fight against terrorist financing17/06/2019 14:38:00
The Council has adopted two important priority files under the Security Union which strengthen EU rules on explosives precursors and facilitate law-enforcement access to financial information.
EU adopts regulation to keep unsafe products off the market17/06/2019 13:25:00
The EU is stepping up efforts to ensure that only products that are safe & compliant with EU legislation can be placed on the market.
Clean Mobility: EC tables proposal on car emissions testing in real driving conditions17/06/2019 13:03:00
In response to a ruling by the General Court, the EC proposes to reinsert certain aspects of Real Driving Emissions testing (RDE) into legislation to be adopted by the European Parliament and Council.
The EU and the United States reach an agreement on imports of hormone-free beef17/06/2019 12:25:00
The EC has shared with Member States the successful outcome of the negotiations to review the functioning of an existing quota to import hormone-free beef into the EU.
EU reports on progress in fighting disinformation ahead of European Council17/06/2019 11:38:00
The EC and the High Representative report on the progress achieved in the fight against disinformation and the main lessons drawn from the European elections, as a contribution to the discussions by EU leaders next week.
EC opens in-depth investigation into public financing of Fehmarn Belt fixed rail-road link17/06/2019 11:07:00
The EC has opened an in-depth investigation to determine whether the public financing model of the Fehmarn Belt fixed rail-road link is in line with EU State aid rules. This follows the EU General Court's annulment of a previous Commission decision approving the support.